Guangrui Hu Selected Research

Proteins (Proteins, Gene)

6/2018

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangrui Hu Research Topics

Disease

3	Neoplasms (Cancer) 01/2019 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
1	Down Syndrome (Down's Syndrome) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Lung Neoplasms (Lung Cancer) 06/2018
1	Leukemia 01/2017

Drug/Important Bio-Agent (IBA)

2	CateninsIBA 01/2022 - 01/2017
2	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 01/2017
2	Long Noncoding RNAIBA 01/2019 - 01/2017
1	Cell Adhesion MoleculesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 06/2018
1	Interferon-gamma (Interferon, gamma)IBA 06/2018
1	ArginaseIBA 06/2018
1	CytokinesIBA 06/2018
1	Glycogen Synthase KinasesIBA 01/2017
1	Transcription Factor 7-Like 2 ProteinIBA 01/2017

Therapy/Procedure

1	Immunotherapy 06/2018
1	Therapeutics 06/2018